← Back
Retatrutide
product
Visit website →
A next-generation GLP-1 drug by Eli Lilly that can help people lose up to a third of their body weight with muscle sparing.
Check price →
Also mentioned
(3)
Casual references without a clear endorsement
Brigham Buhler
mentioned
"Retatrutide is a triple agonist being developed by Eli Lilly. It hits three different receptor si..."
▶ 1:03:23
Andrew Huberman
mentioned
"Retatrutide went through phase three at Lily people can lose up to a third of their body weight i..."
▶ 14:06